Market News

Tenax Therapeutics Q4 2023 Earnings Report Analysis Tenax Therapeutics Q4 2023 Earnings Report Analysis

by Ron Finklestien

Published On: March 28, 2024 9:55 pm

TENX stock - TENX Stock Earnings: Tenax Therapeutics Misses EPS for Q4 2023

Source: iQoncept / Shutterstock

Tenax Therapeutics (NASDAQ:TENX) recently unveiled its performance for the fourth quarter of 2023.

The company reported earnings per share of -$11.84, falling short of the projected EPS of -$8.14.
No revenue was reported by Tenax Therapeutics during the quarter.

InvestorPlace Earnings taps into TradeSmith data to automatically cover quarterly earnings. It highlights crucial metrics like EPS, revenue, and how a company measures against analyst forecasts. These articles are generated without manual input, ensuring prompt dissemination of the latest financials. For queries or corrections, reach out to us at [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/tenx-stock-earnings-tenax-therapeutics-for-q4-of-2023/.

Tenax Therapeutics Q4 2023 Earnings Report Analysis Tenax Therapeutics Q4 2023 Earnings Report Analysis

The free Daily Market Overview 250k traders and investors are reading

Latest Stories

Latest

Stocks Facing Heavy Insider Selling: Three to Watch

Latin America Dominates Mining M&A Activity, Accounting for 75% of Transactions: McKinsey

Embrace the Journey of AI Evolution

Understanding the 81% Decline of Figma Stock: Unseen IPO Factors Affecting Retail Investors

Navigating the Future of Technology Disruption

A Game-Changing Development That Went Unnoticed by Many Investors

Categories

Links

Follow Us On